Paradoxical aggravation of paroxysmal dystonia during chronic treatment with phenobarbital in a genetic rodent model

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.397, Iss.2, 2000-06, pp. : 343-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis

By Richter A. Loscher W.

European Journal of Pharmacology, Vol. 369, Iss. 3, 1999-03 ,pp. : 335-338

Elsevier

Access to resources Recommend Favorite

The kynurenine 3-hydroxylase inhibitor Ro 61-8048 improves dystonia in a genetic model of paroxysmal dyskinesia

By Richter A. Hamann M.

European Journal of Pharmacology, Vol. 478, Iss. 1, 2003-09 ,pp. : 47-52

Elsevier

Access to resources Recommend Favorite

Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia

By Richter A. Loscher W.

European Journal of Pharmacology, Vol. 454, Iss. 2, 2002-11 ,pp. : 145-151

Elsevier

Access to resources Recommend Favorite

Propofol: Paroxysmal dystonia: case report

Reactions Weekly, Vol. 1, Iss. 1396, 2012-01 ,pp. : 34-34

Adis International

Access to resources Recommend Favorite

Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia

By Loscher W. Richter A.

European Journal of Pharmacology, Vol. 391, Iss. 3, 2000-03 ,pp. : 251-254

Elsevier

Access to resources Recommend Favorite